This unique, 1.5-day event is designed for researchers and clinicians who want to engage with pioneering science and accelerate progress.
Highlights include: The latest research on oncolytic viruses, cutting-edge cell therapies, and integrated viral and cellular platforms to enhance immune responses.
Who Should Attend: Scientists, clinicians, postdoctoral fellows, and trainees passionate about advancing cancer treatment.